ALGAIA is a private company backed up by international investors operating in the Health & Nutrition sectors:

About Maabarot Products Ltd

Maabarot is a leading provider of Health and Nutrition products for the Human and Animal market. It was founded in 1963 and counts over 500 employees across the globe. The company is listed on Tel Aviv stock exchange. Maabarot’s mission is to develop, manufacture and supply advanced nutrition & health  products  which  are  reliable,  safe  and  improve  the  quality  of  life  of  its  customers for the benefit of its employees, business partners and shareholders.

About Demeter-Emertec

Demeter-Emertec is the largest European private equity firm in the environmental and energy transition sectors managing over 800 Million Euros. FCPR Emertec 4 is dedicated to fund innovative companies positioned in the field of green chemistry, energy, environment and mobility. Emertec is the initial or primary investor of companies like Fermentalg (micro-algae), Olygose (oligosaccharide of natural origin), Ynsect (insect based proteins for feed and aquaculture applications) or Alderys (green biotech company using yeast as a cell factory)

About Supernova Invest

Supernova Invest combines CEA Investment assets and some of Amundi assets and expertise. Amundi is the largest European private equity investors with over 1000 billion euros in management. CEA Investment, a subsidiary of the CEA, is a specialist in seed investment in technology companies. Its proximity to public research laboratories and the venture capital industry has made it a key player in launching and financing startup companies in France. To date, it has funded over 50 companies. With 15 years’ experience in seed investment, Supernova Invest has generated several successful exits, including companies such as TRACIT, ULIS, MOVEA and FERMENTALG. The investment in ALGAIA was made through the Amorçage Technologique Investissement (ATI) fund, managed by Supernova Invest. The CEA, BPI (using the FNA), EDF, SAFRAN and BIOMERIEUX are investors in ATI.

About CapDecisif Management

CapDecisif Management is a venture capital firm approved by the (Financial Markets Authority) investing in early-stage start-ups based on leading technologies at the crossroads of Life Sciences, Information Technologies and Engineering. It currently manages 5 funds mainly in seed capital for more than 110M€ under management. Founded in 2001, our team has invested in over 76 start-ups mainly in Paris Region.